Meanwhile, Ros, the PPAR-γ agonist treatment, markedly reversed the alleviating effect of Met on CH (Figure 6A) and apoptosis (Figure 6B) in H9c2 cells, indicating that Met attenuated CH depending on the expression of PPAR-γ. Here, PPARG is linked to cyclic hematopoiesis.